Costs of providing HIV care and optimal allocation of HIV resources in Guyana
Suraratdecha, C., Stuart, R.M., Edwards, M., Moore, R., Liu, N., Wilson, D.P., Albalak, R. (2020)
PLoS One

Determining the optimal strategy for reopening schools, the impact of test and trace interventions, and the risk of occurrence of a second COVID-19 epidemic wave in the UK: a modelling study
Panovska-Griffiths, J., Kerr, C.C., Stuart, R.M., Mistry, D., Klein, D.J., Viner, R.M., Bonell, C. (2020)
Lancet Child & Adolescent Health

Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple models
Jewell, B., Mudimu, E., Stover, J. et al. for the HIV Modelling consortium (2020) [Appendix]
Lancet HIV

Sharing the costs of structural interventions: What can models tell us?
Stuart,R.M. and Wilson D.P. (2020)
International Journal of Drug Policy, 102702

The influence of constraints on the efficient allocation of resources for HIV prevention
Stuart, R.M., Kelly, S.L., Kerr, C.C., Martin-Hughes R., and Wilson, D.P. (2019)
AIDS, 33:1949–1956

Optimal allocation of HIV resources among geographical regions
Kedziora, D.J., Stuart, R.M., Pearson, J., Latypov, A., Dierst-Davies, R., Duda, M., Avaliani, N., Wilson, D.P. and Kerr, C.C. (2019)
BMC Public Health, 19:1509

Simulating the entire natural course of HIV infection by extending the basic viral dynamics equations to include declining viral clearance
Petravic, J., Wilson, D.P. (2019)
Pathogens and Disease, Volume 77, Issue 4

What is the impact of a 20% funding cut in international HIV aid from the United States?
ten Brink, D., Martin-Hughes, R., Kelly, S.L., Wilson, D.P. (2019)
AIDS, 33(8):1408-1408

Applying the 'no-one worse off' criterion to design Pareto efficient HIV responses in Sudan and Togo
Stuart, R.M., Haghparast-Bidgoli, H., Panovska-Griffiths, J., Grobicki, L., Skordis, J., Kerr, C.C., Kedziora, D.J., Martin-Hughes, R., Kelly, S.L., Wilson, D.P. (2019)
AIDS, 33(7):1247-1252

A tale of two countries: Progress towards UNAIDS 90-90-90 targets in Botswana and Australia
Marukutira, T., Stoové, M., Lockman, S., Mills, L.A., Gaolathe, T., Lebelonyane, R., Jarvis, J.N., Kelly, S.L., Wilson, D.P., Luchters, S., Crowe, S.M., Hellard, M. (2018)
J Int AIDS Society, 21:e25190

Achieving 90-90-90 Human Immunodeficiency (HIV) targets will not be enough to achieve the HIV incidence reduction target in Australia
Scott, N., Stoové, M., Kelly, S.L., Wilson, D.P., Hellard, M.E. (2018)
Clin Infect Dis, 66(7):1019-1023

Optima attempts to objectively and pragmatically assist countries meet their targets most efficiently and effectively
Wilson, D.P., Gorgens, M., Wilson, D.J. (2018)
J Int AIDS Society, 21:e25190

Cost and Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis among Men Who Have Sex with Men in Two Hospitals of Thailand
Suraratdecha, C., Stuart, R., Manopaiboon, C., Green, D., Lertpiriyasuwat, C., Wilson, D., Pavaputanon, P., Visavakum, P., Monkongdee, P., Khawcharoenporn, T., Tharee, P., Kittinunvorakoon, C., Martin, M. (2018)
J Int AIDS Society, 21:e25129

Optima Nutrition: an allocative efficiency tool to reduce childhood stunting by better targeting of nutrition-related interventions
Pearson, R., Killedar, M., Petravic, J., Kakietek, J.J., Scott, N., Grantham, K.L., Stuart, R.M., Kedziora, D.J., Kerr, C., Skordis-Worrall, J., Shekar, M., Wilson, D.P. (2018)
BMC Public Health, 18(1):384

How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries
Stuart, R.M., Grobicki, L., Haghparast-Bidgoli, H., Skordis-Worrall, J., Keiser, O., Estill, J., Baranczuk, Z., Panovska-Griffiths, J., Kelly, S.L., Reporter, I., Kedziora, D.J., Shattock, A.J., Petravic, J., Hussain, S.A., Grantham, K.L., Gray, R.T., Yap, X.F., Martin-Hughes, R., Benedikt, C.J., Fraser-Hurt, N., Masaki, E., Wilson, D.J., Gorgens, M., Mziray, E., Cheikh, N., Shubber, Z., Kerr, C.C., Wilson, D.P. (2018)
J Int AIDS Society, 21:e25097

The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS
Kelly, S.L., Martin-Hughes, R., Stuart, R.M., Yap, X.F., Kedziora, D.J., Grantham, K.L., Hussain, S.A., Reporter, I., Shattock, A.J., Grobicki, L., Haghparast-Bidgoli, H., Skordis-Worrall, J., Baranczuk, Z., Keiser, O., Estill, J., Petravic, J., Gray, R.T., Benedikt, C.J., Fraser, N., Gorgens, M., Wilson, D., Kerr, C.C., Wilson, D.P. (2018)
Lancet HIV, 5(4):e190-e198

Optimization by Adaptive Stochastic Descent
Kerr, C.C., Dura-Bernal, S., Smolinski, T.G., Chadderdon, G.L., Wilson, D.P. (2018)
PLoS One13(3), e0192944

The City of Johannesburg can end AIDS by 2030: modeling the impact of achieving the fast-track targets and what it will take to get there
Stuart, R.M., Fraser-Hurt, N., Kerr, C.C., Mabusela, E., Madi, V., Mkhwanazi, F. Pillay, Y. Barron, P., Muzah, B., Matsebula, T., Gorgens, M., Wilson, D.P. (2018).
J Int AIDS Society, 21:e25068

Getting it right when budgets are tight: using optimal expansion pathways to prioritize responses to concentrated and mixed HIV epidemics
Stuart, R.M., Kerr, C.C., Haghparast-Bidgoli, H., Estill, J., Grobicki, L., Baranczuk, Z., Prieto, L., Montañez, V., Reporter, I., Gray, R.T., Skordis-Worrall, J., Keiser, O., Cheikh, N., Boonto, K., Osornprasop, S., Lavadenz, F., Benedikt, C.J., Martin-Hughes, R., Hussain, A., Kelly, S.L., Kedziora, D.J., Wilson, D.P. (2017)
PLoS One, 12(10):e0185077

Maximizing the impact of malaria funding through allocative efficiency: using the right interventions in the right locations
Scott, N., Hussain, S.A., Martin-Hughes, R., Fowkes, F.J.I., Kerr, C.C., Pearson, R., Kedziora, D.J., Killedar, M., Stuart, R.M., Wilson, D.P. (2017)
Malaria Journal, 16:368

Acute HIV infection detection and immediate treatment estimated to reduce transmission by 89% among men who have sex with men in Bangkok
Kroon, E.D.M.B., Phanuphak, N., Shattock, A.J., Fletcher, J.L.K., Pinyakorn, S., Chomchey, N., Akapirat, S., de Souza, M.S., Robb, M.L., Kim, J.H.,van Griensven, F. , Ananworanich, J., Wilson, D.P. on behalf of the RV254/SEARCH 010 Study Group. (2017)
J Int AIDS Society, 20:21708

Kazakhstan can achieve ambitious HIV targets by combining improved ART procurement mechanisms with allocative and implementation efficiencies
Shattock, A.J., Benedikt, C., Bokazhanova, A., Đurić, P., Petrenko, I., Ganina, L., Kelly, S.L., Stuart, R.M., Kerr, C.C., Vinichenko, T., Zhang, S., Hamelmann, C., Manova, M., Masaki, E., Wilson, D.P., Gray, R.T. (2016)
PLoS One, 12(2)

Allocative and implementation efficiency in HIV prevention and treatment for people who inject drugs
Benedikt, C., Kelly, S.L., Wilson, D., Wilson, D.P. on behalf of the Optima Consortium. (2016)
Int J Drug Policy, 38:73-80

GBD 2015 and HIV estimates from the Optima model
Kelly, S., Wilson, D.P. (2016)
The Lancet HIV, 3(12):e558

Optimizing HIV/AIDS resources in Armenia: increasing ART investment and examining HIV programs for seasonal migrant laborers.
Kelly, S.L., Shattock, A.J., Kerr, C.C., Stuart, R.M., Papoyan, A., Grigoryan, T., Hovhannisyan, R., Grigoryan, S., Benedikt, C., Wilson, D.P. (2016).
J Int AIDS Society, 19:20772

A no-brainer for ending AIDS: the case for a harm reduction decade
Cook, C., Lines, R., Wilson, D.P. (2016)
J Int AIDS Society, 19:21129

Local responses to local epidemics for national impact need advanced spatially-explicit tools
Grantham, K.L., Kerr, C.C., Wilson, D.P. (2016)
AIDS, 30(9):1481-1482

In the interests of time: improving HIV allocative efficiency modeling via optimal time-varying allocations
Shattock, A.J., Kerr, C.C., Stuart, R.M., Masaki, E., Fraser, N., Benedikt, C., Gorgens, M., Wilson, D.P., Gray, R.T. (2016)
J Int AIDS Society, 19:20627

Projecting the epidemiological effect, cost-effectiveness and transmission of HIV drug resistance in Vietnam associated with viral load monitoring strategies
Pham, Q.D., Wilson, D.P., Nguyen, T.V., Do, N.T., Truong, L.X., Nguyen, L.T., Zhang, L. (2016)
J Antimicrobial Chemotherapy, 71(5):1367-1379

The funding landscape for HIV in Asia and the Pacific
Stuart, R.M., Lief, E., Donald, B., Wilson, D., Wilson, D.P. (2015)
J Int AIDS Society, 18:20004

Sustainable HIV Treatment in Africa through Viral Load-Informed Differentiated Care
Working Group on Modelling of ART Monitoring Strategies in Sub-Saharan Africa (Phillips, A., Shroufi, A., Vojnov, L., Cohn, J., Roberts, T., Ellman, T., Bonner, K., Rousseau, C., Garnett, G., Cambiano, V., Nakagawa, F., Ford, D., Bansi-Matharu, L., Miners, A., Lundgren, J., Eaton, J., Parkes-Rotanshi, R., Katz, Z., Maman, D., Ford, N., Vitoria, M., Doherty, M., Dowdy, D., Nichols, B., Murtagh, M., Wareham, M., Palamountain, K., Musanhu, C.C., Stevens, W., Katzenstein, D., Ciaranello, A., Barnabas, R., Braithwaite, S., Bendavid, E., Nathoo, K.J., van de Vijver, D., Wilson, D., Holmes, C., Bershteyn, A., Walker, S., Raizes, E., Jani, I., Nelson, L., Peeling, R., Terris-Prestholt, F., Murungu, J., Mutasa-Apollo, T., Hallett, T., Revill, P.). (2015)
Nature, 7580(528):S68-S76

Can we know in advance whether models will get it right?
Wilson, D.P., Kerr, C.C. (2015)
The Lancet Global Health, 3(10):e577-578

Re-orienting the HIV response in Niger towards sex work interventions: from better evidence to targeted and expanded practice
Fraser, N., Kerr, C.C., Harouna, Z., Alhousseini, Z., Cheikh, N., Gray, R., Shattock, A., Wilson, D.P., Haacker, M., Shubber, Z., Masaki, E., Karamoko, D., Görgens, M. (2015)
JAIDS, 68:S213–S220

Scaling up HIV treatment for MSM in Bangkok: what does it take? -- a modelling and costing study
Zhang, L., Phanuphak, N., Henderson, K., Nonenoy, S., Srikaew, S., Shattock, A., Kerr, C.C., Omune, B., van Griensven, F., Osornprasop, S., Oelrichs, R., Ananworanich, J., Wilson, D.P. (2015)
Lancet HIV, 2:e200–07

Optima: a model for HIV epidemic analysis, program prioritization, and resource optimization
Kerr, C.C., Stuart, R.M., Gray, R.T., Shattock, A., Fraser-Hurt, N., Benedikt, C., Haacker, M., Berdnikov, M., Mahmood, A.M., Jaber, S.A., Gorgens, M., Wilson, D.P. (2015)
JAIDS, 69(3): 365-376

The cost-effectiveness of harm reduction
Wilson, D.P., Donald, B., Shattock, A.J., Wilson, D., Fraser-Hurt, N. (2015)
Int J Drug Policy, 26(S1):S5-S11

Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models
Eaton, J.W., Menzies, N.A., Stover, J., Cambiano, V., Chindelevitch, L., Cori, A., Hontelez, J.A.C., Humair, S., Kerr, C.C., Klein, D.J., Mishra, S., Mitchell, K.M., Nichols, B.E., Vickerman, P., Bärnighausen, T., Bershteyn, A., Bloom, D.E., Boily, M-C., Chang, S.T., Cohen, T., Dodd, P.J., Fraser, C., Gopalappa, C., Lundgren, J., Martin, N.K., Mountain, E., Pham, Q.D., Pickles, M., Phillips, A., Platt, L., Pretorius, C., Prudden, H.J., Salomon, J.A., van de Vijver, D.A.M.C., Wagner, B.G., White, R.G., Wilson, D.P., Zhang, L., Bandford, J., Meyer-Rath, G., Remme, M., Revill, P., Sangrujee, N., Terris-Prestholt, F., Doherty, M., Easterbrook, P., Hirnschall, G., Hallett, T.B. (2014) [Appendix]
The Lancet Global Health 2:e23-34 

Cost-effectiveness of antiretroviral therapy expansion strategies in Vietnam
Tran, D.A., Wilson, D.P., Zhang, L., Shakeshaft, A., Ngo, A.D., Doran, C. (2014)
AIDS Patient Care and STDs, Jul;28(7):365-71

Reply to PrEP cost-effectiveness
Schneider, K., Gray, R.T., Wilson, D.P. (2014)
Clinical Infectious Diseases, 59 (1):141

Spending of HIV resources in Asia and Eastern Europe: systematic review reveals the need to shift funding allocations towards priority populations
Craig, A.P., Thein, H.H., Zhang, L., Gray, R.T., Henderson, K., Wilson, D., Gorgens, M., Wilson, D.P. (2014)
Journal of the International AIDS Society, 17:18822

Predicting the population impact of increased HIV testing and treatment in Australia
Jansson, J., Kerr, C.C., Wilson, D.P. (2014)
Sexual Health, 11:146–154

How should HIV programmes respond to evidence for the benefits of earlier treatment initiation? A combined analysis of twelve mathematical models
Eaton, J.W., Menzies, N.A., Stover, J., Cambiano, V., Chindelevitch, L., Cori, A., Hontelez, J.A.C., Humair, S., Kerr, C.C., Klein, D.J., Mishra, S., Mitchell, K.M., Nichols, B.E., Vickerman, P., Bakker, R., Bärnighausen, T., Bershteyn, A., Bloom, D.E., Boily M.-C., Chang S.T., Cohen T., Dodd, P.J., Fraser, C., Gopalappa, C., Lundgren, J., Martin N.K., Mikkelsen E., Mountain E., Pham Q.D., Pickles M., Phillips A., Platt L., Pretorius C., Prudden, H.J., Salomon, J.A., van de Vijver, D.A.M.C., de Vlas, S.J., Wagner, B.G., White, R.G., Wilson, D.P., Zhang, L., Blandford, J., Meyer-Rath, G., Remme, M., Revill, P., Sangrujee, N., Terris-Prestholt, F., Doherty, M., Shaffer, N., Easterbrook, P.J., Hirnschall, G., Hallett T.B. (2013)
Lancet Global Health, 2:e23-34

A cost-effectiveness analysis of HIV pre-exposure prophylaxis for men who have sex with men in Australia
Schneider, K., Gray, R.T., Wilson, D.P. (2013)
Clinical Infectious Diseases, 58(7):1027-1034

HIV service capacity: identifying current and future areas of clinical shortage
Mallitt, K.A., Jansson, J., Wand, H., Crooks, L., Wilson, D.P. (2013)
Sexual Health, 11(1):17-23

HIV antiretroviral prophylaxis for injecting drug users
Craig, A.P., Gray, R., Jansson, J., Wilson, D.P. (2013)
The Lancet, 382:854-855

The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South Africa
Schneider, K., Nwizu, C., Kaplan, R., Anderson, J., Wilson, D.P., Emery, S., Cooper, D.A., Boyd, M.A. (2012)
PLoS One, 8(2):e54435

Understanding the modes of transmission model of new HIV infection and its use in prevention planning
Case, K.K., Ghys, P.D., Gouws, E., Eaton, J.W., Borquez, A., Stover, J., Cuchi, P., Abu-Raddad, L.J., Garnett, G.P., Hallett, T.B. on behalf of the HIV Modelling Consortium (Atun, R., Auvert, B., Bacaer, N., Barnighausen, T., Bershteyn, A., Boily, M.-C., Delva, W., Eckhoff, P., Foss, A., Heijne, J., Klein, D.J., Low, N., Lowndes, C.M., Mishra, S., Pretorius, C., Welte, A., White, P., Williams, B., Wilson, D., Wilson, D.P., Zaba, B., Prudden H.). (2012)
Bulletin of the World Health Organization, 90:831-838

Demand for HIV clinical services is increasing in Australia but supply is decreasing
Mallitt, K.A., Jansson, J., Crooks, L., McGuigan, D., Wand, H., Wilson, D.P. (2012)
Sexual Health, 10(1):43-46

HIV Treatment as Prevention: Models, Data, and Questions toward Evidence-Based Decision-Making
The HIV Modelling Consortium Treatment as Prevention Editorial Writing Group (Barnighausen, T., Becker, S., Bendavid, E., Bershteyn, A., Blandford, J., Boily, M.-C., Burns, D., Cambiano, V., Cohen, M.S., Cremin, I., Delva, W., Dye, C., Eaton, J.W., Egger, M., Fraser, C., Galai, N., Garnett, G., Ghys, P.D., Hallett, T.B., Heaton, L., Holmes, C.B., Hontelez, J., Jewell, B., Keiser, O., Klein, D., Lima, V., Long, E., Lyerla, R., Marais, C., Meng, F., Meyer-Rath, G., Miller, W.C., Muraguri, N., Nichols, B.E., Nigmatulina, K.R., Over, M., Padian, N., Phillips, A., Pretorius, C., Rousseau, C., Salomon, J., Sangrujee, N., Serwadda, D., Tanser, F., Vesga, J.F., Vickerman, P., Walker, D., Wang, R., Welte, A., White, R.G., Williams, B., Wilson, D.P., Wilson, D., Zaba B.). (2012)
PLoS Medicine, 9(7):e1001259

Estimating the cost-effectiveness of needle-syringe programs in Australia.
Kwon J.A., Anderson J., Kerr C.C., Thein H.H., Zhang L., Iversen J., Dore G.J., Kaldor J.M., Law M.G., Maher L., Wilson D. (2012) [Appendix]
AIDS 26(17):2201-10 

Projected demographic profile of people living with HIV in Australia: planning for an older generation
Jansson, J., Wilson, D.P. (2012)
PLoS One, 7(8):e38334

HIV Treatment as Prevention: Principles of Good HIV Epidemiology Modelling For Public Health Decision-Making in All Modes of Prevention and Evaluation
Delva, W., Wilson, D.P., Abu-Raddad, L., Gorgens, M., Wilson, D., Hallett, T.B., Welte, A. (2012)
PLoS Medicine, 9(7):e1001239

HIV Treatment as Prevention: Natural experiments highlight limits of antiretroviral treatment as HIV prevention
Wilson, D.P. (2012)
PLoS Medicine, 9(7):e1001231

Expected epidemiological impacts of introducing an HIV vaccine in Thailand: a model-based analysis
Schneider, K., Kerr, C.C., Hoare, A., Wilson, D.P. (2011)
Vaccine, 29:6086-6091

Expected epidemiological impact of the introduction of a partially effective HIV vaccine among men who have sex with men in Australia
Gray, R.T., Ghaus, M.H., Hoare, A., Wilson, D.P. (2011)
Vaccine, 29:6125-6129

Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings
Schneider, K., Puthanakit, T., Kerr, S., Law, M.G., Cooper, D.A., Donovan, B., Phanuphak, N., Sirisanthana, V., Ananworanich, J., Ohata, J., Wilson, D.P. (2011)
AIDS, 25:1143-1151

What impact might the economic crisis have on HIV epidemics in Southeast Asia?
Gray, R.T., Heymer, K.J., Hoare, A., Kwon, J.A., Thein, H.H., Lote, N., Siba, P., Saramony, S., Saphonn, V., Worth, H., Kaldor, J.M., Wilson, D.P. (2009)
Current HIV Research, 7:656-665

Cost-effectiveness of adult circumcision for HIV prevention in men who have sex with men in a resource-rich setting
Anderson, J.S., Wilson, D.P., Templeton, D.J., Grulich, A.E., Carter, R., Kaldor, J.M. (2009)
Journal of Infectious Disease, 200:1803-1812

The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis
Kwon, J.A., Iversen, J., Maher, L., Law, M.G., Wilson, D.P. (2009)
J AIDS, 51(4):462-469

Relation between HIV viral load and infectiousness? A model-based analysis
Wilson, D.P., Law, M.G., Grulich, A.E., Cooper, D.A., Kaldor, J.M. (2008)
The Lancet, 372:314-20

The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics
Wilson, D.P., Coplan, P.M., Wainberg, M.A., Blower, S.M. (2008)
PNAS, 105(28):9835-40

Mathematical models and health economic aspects of microbicides
Wilson, D.P., Coplan, P.M. (2008)
Current Opinion in HIV and AIDS, 3:587-592

Using mathematical modelling to help explain the differential increase in HIV incidence in New South Wales, Victoria, and Queensland: the importance of other STIs
Hoare, A., Wilson, D.P., Regan, D.G., Kaldor, J., Law, M.G. (2008)
Sexual Health, 5:169-187

Predicting the epidemiological impact of antiretroviral allocation strategies in KwaZulu-Natal: The effect of the urban-rural divide
Wilson, D.P., Kahn, J.O., Blower, S.M. (2006)
PNAS, 103(38):14228-14233

Rational choices for allocating antiretrovirals in Africa: treatment equity, epidemiological efficiency and feasibility
Wilson, D.P., Blower, S.M. (2006)
PLoS Medicine, 3(3), e160

Allocating Antiretrovirals in South Africa: Using Modeling to Determine Treatment Equity
Wilson, D.P., Blower, S.M. (2005)
PLoS Medicine, 2(6):563-564

Designing Equitable Antiretroviral Allocation Strategies in Resource-Constrained Countries
Wilson, D.P., Blower, S.M. (2005)
PLoS Medicine, 2(2):132-141

Optimizing investments in the tuberculosis response in Blantyre, Lilongwe, and Mzimba districts, Malawi: results of a TB allocative efficiency study (2020)

Burnet Institute, the World Bank Group

Tuberculosis in Indonesia: epidemic projections and opportunities to accelerate control: findings from an Optima TB analysis (2020)

Burnet Institute, the World Bank Group

Optimizing investments in the tuberculosis response of Gauteng province, South Africa: findings from a pilot application of the Optima TB model (2020)

Burnet Institute, the World Bank Group

Optimizing investments in Mozambique's tuberculosis response: results of a tuberculosis efficiency study (2019)

National TB Program Mozambique, World Bank, University College London, Burnet Institute

Optimizing investment in Romania's tuberculosis response (2019)

Burnet Institute, the World Bank Group

Optimizing investments in Moldova’s tuberculosis response (2018)

Burnet Institute, the World Bank Group, IMSP Phthisiopneumology Institute, PAS, Ministry of Health Moldova

Optimizing investments in Belarus’ tuberculosis response (2017)

The World Bank Group for the Government of Belarus

Ending AIDS in Johannesburg: An analysis of the status and scale-up towards HIV treatment and prevention targets.

Burnet Institute, Optima Consortium for Decision Science (2016)

The World Bank Group for the Gauteng Province Department of Health and South African Department of Health

Optimizing Investments for a Sustainable and Efficient HIV Response in Senegal: Findings from an HIV Allocative Efficiency Study

Government of Senegal, UNAIDS, the Optima Consortium for Decision Science, the University of Bern, the University of New South Wales, the Kirby Institute, and the Burnet Institute (2016)

The World Bank Group

HIV Investment in Cote d’Ivoire: Optimized allocation of HIV resources for a sustainable and efficient HIV response

University of Bern, University of New South Wales, Burnet Institute, and The World Bank (2016)

The World Bank Group

Optimizing investments in Bulgaria’s HIV response

University College London, Burnet Institute, University of New South Wales (2016)

The World Bank Group, Global Fund, UINAIDS, and UNDP for the Government of Bulgaria

Optimizing investments in Belarus for the National HIV Response

Atroshchanka O., Fisenka A., Ilyenkova V., Đurić P., Gray R., Benedikt C., Masaki E., Obst M., Kokiashvili D., Maxim C., Sakvarelidze G., Zhang S., Hailevich R., Manova M., Hamelmann C., Kerr C., Stuart R., Wilson D.P., Görgens M., Nguyen S.N., Wilson D. (2016)

The World Bank Group

Optimizing Investments in the Kyrgyz Republic’s HIV Response

Maitieva V., Ianbukhtina L., Mambetov T., Bashmakova L., Sarybaeva M., Đurić P., Shattock A., Benedikt C., Masaki E., Obst M., Soorombaeva D., Abarbekova A., Kazizova M., Irbe S., Kokiashvili D., Mdivani N., Zhang S., Hailevich R., Manova M., Scutelniciuc O., Hamelmann C., Macauley J., Stuart R., Kerr C., Wilson D.P., Patel R., Nguyen S.N., Görgens M. (2016)

The World Bank Group

Value for money in Ukraine’s HIV response: strategic investment and improved efficiency

Kuzin I., Sharapka K., Gvozdeva E., Kerr C., Stuart R., Masaki E., Goroshko A., Benedikt C., Nizova N., Wilson D.P., Boyko J., Belli P., Görgens M., Wilson D., Manova M., Hailevich R., Tyszko J., Đurić P., Hamelmann c., Zhang S., Sakvarelidze G., Görgens M., Belli P., Doroshenko O., Fraser N., Garcia R.R., Shubber Z. (2016)

The World Bank Group

Optimizing Investments in Georgia’s HIV Response

Asatiani A., Baliashvili D., Khonelidze I., Ruadze E., Stvilia K., Tsereteli M., Chokoshvili O., Haghparast-Bidgoli H., Grobicki L., Panovska-Griffiths J., Skordis-Worrall J., Benedikt C., Kerr C., Stuart R., Wilson D.P., Görgens M., Masaki E., Hailevic R., Manova M., Kokiashvili D., Loncar D., Sakanyan T., Zhang S., Đurić P., Hamelmann C. (2016)

The World Bank Group

Optimizing HIV Investments in Armenia

Grigoryan S., Grigoryan T., Hovhannisyan R., Papoyan A., Kelly S., Benedikt C., Cuadros D.F., Masaki E., Obst M., Grishechkina V., Kokiashvili D., Zhang S., Hailevich R., Manova M., Đurić P., Hamelmann C., Kerr C., Stuart R., Wilson D.P., Nguyen S.N., Görgens M., Heard W. (2016)

The World Bank Group

Optimizing investments in Kazakhstan’s HIV response

Baiserkin B.S., Bokazhanova A., Ganina L.U., Kalinich N.F., Kazimova A.A., Petrenko I.I., Yelizarieva A.V., Đurić P., Shattock A., Benedikt C., Masaki E., Obst M., Farcy N., Kokiashvili D., Vinichenko T., Zhang S., Hailevich R., Manova M., Scutelniciuc O., Hamelmann C., Kerr C., Stuart R.M., Wilson D.P., Nguyen S.N., Görgens M., Wilson D., Patel R., Bortman M., Zhumadil B. (2016)

The World Bank Group

Evaluation of a Decade of DFID and World Bank Supported HIV and AIDS Programmes in Vietnam from 2003 to 2012

Zhang L., Maher L., Pham D.Q., Higgs P., Anh N.D., Duc B.H. Shattock A., Hoa D.M., Wilson D.P. (2014)

The World Bank Group